A detailed history of Epoch Investment Partners, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 569,103 shares of JNJ stock, worth $88.3 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
569,103
Previous 575,286 1.07%
Holding current value
$88.3 Million
Previous $84.1 Million 9.69%
% of portfolio
0.43%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $899,502 - $1.03 Million
-6,183 Reduced 1.07%
569,103 $92.2 Million
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $1.68 Million - $1.83 Million
11,630 Added 2.06%
575,286 $84.1 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $8.35 Million - $8.75 Million
-53,776 Reduced 8.71%
563,656 $89.2 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $35 Million - $38.1 Million
-240,110 Reduced 28.0%
617,432 $96.8 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $4.67 Million - $5.23 Million
-29,955 Reduced 3.38%
857,542 $134 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $1.63 Million - $1.75 Million
10,530 Added 1.2%
887,497 $147 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $5.56 Million - $6.64 Million
36,838 Added 4.38%
876,967 $136 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $3.33 Million - $3.74 Million
-20,816 Reduced 2.42%
840,129 $148 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $2.29 Million - $2.55 Million
-14,217 Reduced 1.62%
860,945 $141 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $9.44 Million - $10.4 Million
-56,139 Reduced 6.03%
875,162 $155 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $15.6 Million - $17.7 Million
98,687 Added 11.85%
931,301 $165 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $6.7 Million - $7.44 Million
-42,995 Reduced 4.91%
832,614 $142 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $1.96 Million - $2.18 Million
12,121 Added 1.4%
875,609 $141 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $28.2 Million - $30.3 Million
-176,897 Reduced 17.0%
863,488 $142 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $3.03 Million - $3.38 Million
19,822 Added 1.94%
1,040,385 $171 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $15.1 Million - $17.3 Million
-110,131 Reduced 9.74%
1,020,563 $161 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $7.01 Million - $7.68 Million
-49,956 Reduced 4.23%
1,130,694 $168 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $10.5 Million - $12.7 Million
-81,726 Reduced 6.47%
1,180,650 $166 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $20.6 Million - $28.6 Million
185,722 Added 17.25%
1,262,376 $166 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $748,935 - $860,188
-5,874 Reduced 0.54%
1,076,654 $157 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $26.2 Million - $29.3 Million
206,142 Added 23.52%
1,082,528 $140 Million
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $9.35 Million - $10.3 Million
-71,290 Reduced 7.52%
876,386 $122 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $6.02 Million - $6.69 Million
-47,877 Reduced 4.81%
947,676 $132 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $12.2 Million - $14.7 Million
-99,364 Reduced 9.08%
995,553 $128 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $8.48 Million - $9.97 Million
-69,754 Reduced 5.99%
1,094,917 $151 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $10.8 Million - $11.9 Million
-90,253 Reduced 7.19%
1,164,671 $141 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $8.29 Million - $9.81 Million
-66,252 Reduced 5.01%
1,254,924 $161 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $3.56 Million - $3.89 Million
-27,112 Reduced 2.01%
1,321,176 $185 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $175 Million - $183 Million
1,348,288
1,348,288 $175 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.